𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Phase II study of high-dose thiotepa and hematopoietic stem cell transplantation in children with solid tumors

✍ Scribed by Lucidarme, N; Valteau-Couanet, D; Oberlin, O; Couanet, D; Kalifa, C; Beaujean, F; Lapierre, V; Hartmann, O


Book ID
110010706
Publisher
Nature Publishing Group
Year
1998
Tongue
English
Weight
48 KB
Volume
22
Category
Article
ISSN
0007-1188

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Phase I study of high-dose thiotepa with
✍ Pession, Andrea; Prete, Arcangelo; Locatelli, Franco; Bella, Santiago; Melchiond πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 70 KB πŸ‘ 2 views

Background. The aim of this phase I study was to define the maximum tolerated dose (MTD) of thiotepa (TT), administered with busulfan (BU) 480 mg/m 2 and etoposide 2,400 mg/m 2 , followed by autologous bone marrow transplantation (ABMT) or peripheral blood stem cell transplantation (APBSCT) support